Skip to main content
. 2015 Jun 18;47(2):465–472. doi: 10.3892/ijo.2015.3054

Figure 1.

Figure 1

Glioblastoma cell lines A-172, T-98G and U-87. Cells were grown for 24 h at a density of 500 cells per well in 384-well plates. IBET-151, PRP peptide, or vehicle controls (DMSO for IBET-151, saline for PRP) were added directly into the wells. Each condition was tested in triplicate. After 72 h, a CellTiter-Glo Luminescent Cell Viability assay (Promega) was performed.